Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol

Figure 2

Effect of resveratrol on red blood cell aggregation. Values are expressed as . Star () = significant difference in 3^rd month values of the resveratrol group compared to the baseline values of the resveratrol group (). Baseline: measured values at randomization in the resveratrol or placebo group; 3^rd month: patients treated with resveratrol or placebo for 3 months; value: aggregation index at 3 s^-1 rotation speed of the Myrenne aggregometer; AI: aggregation index measured by LORCA aggregometer; (s): aggregation half time; (1/s): threshold shear rate.